Ann Cranney

Summary

Affiliation: Queen's University
Country: Canada

Publications

  1. ncbi request reprint Hormone replacement therapy for postmenopausal osteoporosis
    Ann Cranney
    Division of Rheumatology, Department of Medicine, Queen s University, Etherington Hall, Room 2004, 94 Stuart Street, Kingston, Ontario, Canada, K7L 3N4
    Clin Geriatr Med 19:361-70. 2003
  2. pmc The Canadian celiac health survey--the Ottawa chapter pilot
    Ann Cranney
    Division of Rheumatology, Department of Medicine, Queen s University, Kingston, Ontario, Canada
    BMC Gastroenterol 3:8. 2003
  3. ncbi request reprint Hip protectors decrease hip fracture risk in elderly nursing home residents: a Bayesian meta-analysis
    Anna M Sawka
    Division of Endocrinology and Department of Medicine, University Health Network, University of Toronto, Toronto, Ontario, Canada
    J Clin Epidemiol 60:336-44. 2007
  4. ncbi request reprint The Canadian Celiac Health Survey
    Ann Cranney
    Department of Medicine, Ottawa Health Research Institute, University of Ottawa, Ottawa, Ontario, Canada
    Dig Dis Sci 52:1087-95. 2007
  5. pmc A scoping review of strategies for the prevention of hip fracture in elderly nursing home residents
    Anna M Sawka
    Division of Endocrinology, Department of Medicine, University Health Network, Toronto, Ontario, Canada
    PLoS ONE 5:e9515. 2010
  6. ncbi request reprint Understanding and overcoming the barriers of implementing patient decision aids in clinical practice
    Siobhan O'Donnell
    Clinical Epidemiology Program, Ottawa Health Research Institute, Ottawa, Ontario, Canada
    J Eval Clin Pract 12:174-81. 2006
  7. pmc Do patients perceive a link between a fragility fracture and osteoporosis?
    Lora Giangregorio
    Department of Kinesiology, University of Waterloo, Waterloo, Ontario, Canada
    BMC Musculoskelet Disord 9:38. 2008
  8. doi request reprint Trends in hip fracture rates in Canada
    William D Leslie
    Department of Medicine, University of Manitoba, Winnipeg, Canada
    JAMA 302:883-9. 2009
  9. ncbi request reprint Do hip protectors decrease the risk of hip fracture in institutional and community-dwelling elderly? A systematic review and meta-analysis of randomized controlled trials
    Anna M Sawka
    Division of Endocrinology and Department of Medicine, St Joseph s Healthcare and McMaster University, Hamilton, Ontario, Canada
    Osteoporos Int 16:1461-74. 2005
  10. ncbi request reprint Benefit-risk assessment of raloxifene in postmenopausal osteoporosis
    Ann Cranney
    Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
    Drug Saf 28:721-30. 2005

Collaborators

Detail Information

Publications39

  1. ncbi request reprint Hormone replacement therapy for postmenopausal osteoporosis
    Ann Cranney
    Division of Rheumatology, Department of Medicine, Queen s University, Etherington Hall, Room 2004, 94 Stuart Street, Kingston, Ontario, Canada, K7L 3N4
    Clin Geriatr Med 19:361-70. 2003
    ..The unfavorable risk/benefit profile of HRT, however, strongly limits its use for prevention of osteoporosis, given that there are other medications that have demonstrated fracture efficacy...
  2. pmc The Canadian celiac health survey--the Ottawa chapter pilot
    Ann Cranney
    Division of Rheumatology, Department of Medicine, Queen s University, Kingston, Ontario, Canada
    BMC Gastroenterol 3:8. 2003
    ..Our objective was to determine the feasibility of surveying over 5,000 members of the CCA, in addition to obtaining more health related information about celiac disease...
  3. ncbi request reprint Hip protectors decrease hip fracture risk in elderly nursing home residents: a Bayesian meta-analysis
    Anna M Sawka
    Division of Endocrinology and Department of Medicine, University Health Network, University of Toronto, Toronto, Ontario, Canada
    J Clin Epidemiol 60:336-44. 2007
    ....
  4. ncbi request reprint The Canadian Celiac Health Survey
    Ann Cranney
    Department of Medicine, Ottawa Health Research Institute, University of Ottawa, Ottawa, Ontario, Canada
    Dig Dis Sci 52:1087-95. 2007
    ..More accurate food labeling is needed. Improved awareness of celiac disease and greater use of serological screening tests may result in earlier diagnosis and reduced risk of associated conditions...
  5. pmc A scoping review of strategies for the prevention of hip fracture in elderly nursing home residents
    Anna M Sawka
    Division of Endocrinology, Department of Medicine, University Health Network, Toronto, Ontario, Canada
    PLoS ONE 5:e9515. 2010
    ..Elderly nursing home residents are at increased risk of hip fracture; however, the efficacy of fracture prevention strategies in this population is unclear...
  6. ncbi request reprint Understanding and overcoming the barriers of implementing patient decision aids in clinical practice
    Siobhan O'Donnell
    Clinical Epidemiology Program, Ottawa Health Research Institute, Ottawa, Ontario, Canada
    J Eval Clin Pract 12:174-81. 2006
    ..This report is based on our interpretation of the literature and our collective experience in implementing ptDAs within trials and other contexts...
  7. pmc Do patients perceive a link between a fragility fracture and osteoporosis?
    Lora Giangregorio
    Department of Kinesiology, University of Waterloo, Waterloo, Ontario, Canada
    BMC Musculoskelet Disord 9:38. 2008
    ..To evaluate factors associated with whether patients associate their fracture with future fracture risk...
  8. doi request reprint Trends in hip fracture rates in Canada
    William D Leslie
    Department of Medicine, University of Manitoba, Winnipeg, Canada
    JAMA 302:883-9. 2009
    ..Hip fractures are a public health concern because they are associated with significant morbidity, excess mortality, and the majority of the costs directly attributable to osteoporosis...
  9. ncbi request reprint Do hip protectors decrease the risk of hip fracture in institutional and community-dwelling elderly? A systematic review and meta-analysis of randomized controlled trials
    Anna M Sawka
    Division of Endocrinology and Department of Medicine, St Joseph s Healthcare and McMaster University, Hamilton, Ontario, Canada
    Osteoporos Int 16:1461-74. 2005
    ..Thus, there is little evidence to support the use of hip protectors outside the nursing home setting. The potential benefit of hip protectors in reducing hip fractures in nursing home residents requires further confirmation...
  10. ncbi request reprint Benefit-risk assessment of raloxifene in postmenopausal osteoporosis
    Ann Cranney
    Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
    Drug Saf 28:721-30. 2005
    ..Raloxifene can be recommended for the prevention of vertebral fractures in women with osteopenia/osteoporosis who are not at high risk of non-vertebral fractures and who do not have a past history of venous thromboembolism...
  11. ncbi request reprint Summary of evidence-based review on vitamin D efficacy and safety in relation to bone health
    Ann Cranney
    Clinical Epidemiology Program, Ottawa Health Research Institute, Ottawa Hospital, and The University of Ottawa Evidence based Practice Center, Ottawa, Ontario, Canada
    Am J Clin Nutr 88:513S-519S. 2008
    ..We found fair evidence that adults tolerated vitamin D at doses above current dietary reference intake levels, but we had no data on the association between long-term harms and higher doses of vitamin D...
  12. ncbi request reprint Economic evaluation of norethisterone acetate/ethinylestradiol (FemHRT) for women with menopausal symptoms
    Douglas Coyle
    Clinical Epidemiology, Ottawa Health Research Institute, Ottawa Hospital Department of Medicine and Epidemiology, University of Ottawa, Ottawa, Ontario, Canada
    Pharmacoeconomics 21:661-9. 2003
    ....
  13. doi request reprint Systematic review of the benefits and harms of calcitriol and alfacalcidol for fractures and falls
    Siobhan O'Donnell
    Clinical Epidemiology Program, Ottawa Health Research Institute, 1053 Carling Avenue, ASB 1 006, Ottawa, Ontario, Canada, K1Y 4E9
    J Bone Miner Metab 26:531-42. 2008
    ..Hypercalcemia and hypercalciuria are potential side effects...
  14. ncbi request reprint Stability of normative data for the SF-36: results of a three-year prospective study in middle-aged Canadians
    Wilma M Hopman
    Clinical Research Centre, Kingston General Hospital and Department of Community Health and Epidemiology, Queen s University, Kingston, ON
    Can J Public Health 95:387-91. 2004
    ..This paper assesses mean changes in SF-36 scores over a 3-year period in men and women between the ages of 40 and 59 years at baseline...
  15. doi request reprint Hip fracture and proton pump inhibitor therapy: balancing the evidence for benefit and harm
    Paul Moayyedi
    Division of Gastroenterology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Am J Gastroenterol 103:2428-31. 2008
    ..The association between proton pump inhibitor therapy and hip fracture is a good illustration of this dilemma. We use this example to highlight an approach that can be taken to critically evaluate the evidence for harms of medication...
  16. ncbi request reprint Development and pilot testing of a decision aid for postmenopausal women with osteoporosis
    Ann Cranney
    Department of Medicine, Ottawa Hospital, C4 CEU, 1053 Carling Avenue, Ontario, Canada K1Y4 E9
    Patient Educ Couns 47:245-55. 2002
    ..Our decision aid shows promise in preparing women for counseling about osteoporosis therapies. Long-term adherence to chosen therapy and quality of life will be evaluated in a randomized controlled trial...
  17. ncbi request reprint Corticosteroid-induced osteoporosis: a guide to optimum management
    Ann Cranney
    Queen s University, Kingston, Ontario, Canada
    Treat Endocrinol 1:271-9. 2002
    ..Teriparatide (recombinant human parathyroid hormone 1-34) shows promise as a future anabolic agent for the prevention and treatment of patients with corticosteroid-induced osteoporosis...
  18. ncbi request reprint Quality of life in patients with rheumatoid arthritis : which drugs might make a difference?
    Barbara Blumenauer
    Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada
    Pharmacoeconomics 21:927-40. 2003
    ..Further study is required to determine the response of QOL to treatment in patients with refractory RA and instruments with known MCIDs should be used so that the clinical significance of the improvement can be determined...
  19. ncbi request reprint Summary of meta-analyses of therapies for postmenopausal osteoporosis and the relationship between bone density and fractures
    Gordon H Guyatt
    Department of Medicine, Department of Clinical Epidemiology and Biostatistics, McMaster University, 1200 Main Street West, Hamilton, Ontario, Canada, L8N 3Z5
    Endocrinol Metab Clin North Am 31:659-79, xii. 2002
    ..We also outline other important facets of the decision-making process regarding osteoporosis therapy, including attitudes toward uncertainty, circumstances, and patients' and societal preferences...
  20. ncbi request reprint Meta-analyses of therapies for postmenopausal osteoporosis. I. Systematic reviews of randomized trials in osteoporosis: introduction and methodology
    Ann Cranney
    McMaster University, Department of Clinical Epidemiology and Biostatistics, Hamilton, Ontario, Canada
    Endocr Rev 23:496-507. 2002
  21. ncbi request reprint The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review
    Catherine Dube
    Gastrointestinal Clinical Research Unit, University of Ottawa, Ottawa, Ontario, Canada
    Gastroenterology 128:S57-67. 2005
    ..The prevalence is higher still in high-risk groups. Clinicians in a variety of specialties should have a high index of suspicion for the diagnosis of CD and in particular need to pay close attention to the identified high-risk groups...
  22. ncbi request reprint Cost-effectiveness of hip protectors in institutional dwelling elderly
    Lisa Waldegger
    Clinical Epidemiology Program, Ottawa Health Research Institute, Ottawa Hospital, Ottawa, Ontario, Canada
    Osteoporos Int 14:243-50. 2003
    ..To assess the effectiveness and cost-effectiveness of hip protectors in the prevention of hip fracture in an elderly population living in institutions...
  23. ncbi request reprint Consequences of testing for celiac disease
    Ann Cranney
    Ottawa Health Research Institute, Ottawa, Canada
    Gastroenterology 128:S109-20. 2005
    ..The literature suggests that compliance is less than ideal in these individuals, especially if diagnosed when adults. Long-term outcomes have not been extensively studied in those with silent CD...
  24. pmc Low bone mineral density and fracture burden in postmenopausal women
    Ann Cranney
    Clinical Epidemiology Program, Ottawa Health Research Institute, Ottawa, Ont
    CMAJ 177:575-80. 2007
    ..5 or less), and to contrast fracture patterns among women 50 to 64 years of age with those among women 65 years of age and older...
  25. ncbi request reprint Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women
    George Wells
    Endocr Rev 23:529-39. 2002
    ..To review the effect of hormone replacement therapy (HRT) on bone density and fractures in postmenopausal women...
  26. ncbi request reprint Meta-analyses of therapies for postmenopausal osteoporosis. IV. Meta-analysis of raloxifene for the prevention and treatment of postmenopausal osteoporosis
    Ann Cranney
    Endocr Rev 23:524-8. 2002
    ..To review the effect of raloxifene on bone density and fractures in postmenopausal women...
  27. ncbi request reprint Meta-analyses of therapies for postmenopausal osteoporosis. III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis
    Ann Cranney
    Endocr Rev 23:517-23. 2002
    ..To review the effect of risedronate on bone density and fractures in postmenopausal women...
  28. ncbi request reprint Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women
    Ann Cranney
    Endocr Rev 23:508-16. 2002
    ..To review the effect of alendronate on bone density and fractures in postmenopausal women...
  29. pmc Physicians' intentions and use of three patient decision aids
    Ian D Graham
    Ottawa Health Research Institute, Clinical Epidemiology Program, Ottawa, ON, Canada
    BMC Med Inform Decis Mak 7:20. 2007
    ..The purpose of this study was to describe physicians' perceptions of three decision aids, their expressed intent to use them, and their subsequent use of them...
  30. ncbi request reprint Meta-analyses of therapies for postmenopausal osteoporosis. VI. Meta-analysis of calcitonin for the treatment of postmenopausal osteoporosis
    Ann Cranney
    Endocr Rev 23:540-51. 2002
    ..To review the effect of calcitonin on bone density and fractures in postmenopausal women...
  31. ncbi request reprint Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis
    Beverley Shea
    Endocr Rev 23:552-9. 2002
    ..To summarize controlled trials examining the effect of calcium on bone density and fractures in postmenopausal women...
  32. pmc Parathyroid hormone for the treatment of osteoporosis: a systematic review
    Ann Cranney
    Department of Medicine, University of Ottawa, Ottawa, Ont
    CMAJ 175:52-9. 2006
    ....
  33. ncbi request reprint Meta-analyses of therapies for postmenopausal osteoporosis. VIII: Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women
    Emmanuel Papadimitropoulos
    Endocr Rev 23:560-9. 2002
    ..To review the effect of vitamin D on bone density and fractures in postmenopausal women...
  34. ncbi request reprint Celiac disease: evaluation of the diagnosis and dietary compliance in Canadian children
    Mohsin Rashid
    Division of Gastroenterology and Nutrition, Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada
    Pediatrics 116:e754-9. 2005
    ..We sought to characterize the clinical features at presentation as well as the associated disorders, family history, and evaluation of compliance with a gluten-free diet in children with celiac disease from across Canada...
  35. ncbi request reprint Evaluation of in-hospital management of fracture risk in older patients: a chart review study of tertiary prevention
    Anna M Byszewski
    Division of Geriatric Medicine, The Ottawa Hospital, Civic Campus, 1053 Carling Avenue, Ottawa, Ont, Canada K1Y 4E9
    Arch Gerontol Geriatr 42:319-28. 2006
    ..Interventions are required to increase the awareness that this problem is not being addressed at the time of hospitalization and that on discharge, patients will need follow-up by the treating community physician...
  36. ncbi request reprint Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis
    Ann Cranney
    Endocr Rev 23:570-8. 2002
    ....
  37. ncbi request reprint Rational use of oral bisphosphonates for the treatment of osteoporosis
    Julian M R Mathoo
    McMaster University, 201 25 Charlton Ave E, Hamiton, Ontario, L8N 1Y2 Canada
    Curr Osteoporos Rep 2:17-23. 2004
    ..Once-weekly dosing options with alendronate and risedronate are effective and reduce serious adverse drug effects, and therefore, are welcome additions to our therapeutic armamentarium...
  38. ncbi request reprint The diagnostic accuracy of serologic tests for celiac disease: a systematic review
    Alaa Rostom
    Gastrointestinal Clinical Research Unit, University of Ottawa, Ottawa, Canada
    Gastroenterology 128:S38-46. 2005
    ..If true, the nearly perfect negative predictive value of these tests would drop. The positive predictive value of these tests is likely lower than reported when the tests are applied in low-prevalence populations...